RxDoctor Payments Data

Joe Braden, PA

Physician Assistant · Apollo Beach, FLNPI 1619960804

Payments from drug & device makers

$7,040in general payments, 2019–2025

Across 395 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$984
  • Lilly USA, LLC$902
  • Bayer$524
  • Novo Nordisk$494
  • Pfizer$366
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$360
  • plus $3K from 43 others

What the payments were for

  • Food & beverage$7,040100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,040 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$37,846
Medicare patients
227
Services billed
1,483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide77$121,960
OzempicSemaglutide40$77,388
EliquisApixaban43$61,213
JardianceEmpagliflozin24$42,294
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$21,930
JanuviaSitagliptin Phosphate18$20,889
FarxigaDapagliflozin Propanediol11$20,047
SymbicortBudesonide/Formoterol Fumarate17$5,440
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$2,607
Albuterol Sulfate HfaAlbuterol Sulfate90$2,478
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$2,420
Ezetimibe52$2,353
Doxycycline Monohydrate145$1,815
Atorvastatin Calcium220$1,619
Prednisone131$1,608

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$902$121,96077 claims
Novo NordiskOzempic$494$77,38840 claims
PfizerEliquis$366$61,21343 claims
Boehringer IngelheimJardiance$283$42,29424 claims
AstraZenecaFarxiga, Symbicort$320$25,48728 claims
GSKTrelegy Ellipta$191$21,93013 claims
MerckJanuvia$84$20,88918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Apollo Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →